tiprankstipranks
Trending News
More News >
CSPC Pharmaceutical Group Limited (CHJTF)
OTHER OTC:CHJTF
US Market

CSPC Pharmaceutical Group (CHJTF) Income Statement

Compare
27 Followers

CSPC Pharmaceutical Group Income Statement

Last quarter (Q2 2025), CSPC Pharmaceutical Group's total revenue was ¥14.26B, a decrease of -15.15% from the same quarter last year. In Q2, CSPC Pharmaceutical Group's net income was ¥2.74B. See CSPC Pharmaceutical Group’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 29.54B¥ 31.47B¥ 31.59B¥ 27.41B¥ 23.58B
Gross Profit
¥ 20.67B¥ 22.19B¥ 22.73B¥ 20.79B¥ 17.67B
Operating Expenses
¥ 15.22B¥ 15.19B¥ 15.80B¥ 14.64B¥ 12.53B
Depreciation and Amortization
¥ 1.36B¥ 1.11B¥ 1.07B¥ 849.47M¥ 763.04M
EBITDA
¥ 7.18B¥ 8.59B¥ 8.85B¥ 7.57B¥ 6.80B
Operating Income
¥ 5.45B¥ 7.01B¥ 6.93B¥ 6.14B¥ 5.14B
Other Income/Expenses
¥ 229.71M¥ 388.72M¥ 811.55M¥ 591.96M¥ 904.76M
Pretax Income
¥ 5.68B¥ 7.39B¥ 7.74B¥ 6.73B¥ 6.04B
Net Income
¥ 4.41B¥ 5.88B¥ 6.22B¥ 5.51B¥ 4.88B
Per Share Metrics
Basic EPS
¥ 0.38¥ 0.50¥ 0.52¥ 0.46¥ 0.41
Diluted EPS
¥ 0.38¥ 0.49¥ 0.52¥ 0.46¥ 0.41
Weighted Average Shares Outstanding
11.74B 11.87B 11.92B 11.95B 11.95B
Weighted Average Shares Outstanding (Diluted)
11.74B 11.87B 11.92B 11.95B 11.96B
Currency in CNY

CSPC Pharmaceutical Group Earnings and Revenue History